{"id":585,"date":"2020-08-28T09:22:26","date_gmt":"2020-08-28T16:22:26","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=585"},"modified":"2020-09-03T09:23:18","modified_gmt":"2020-09-03T16:23:18","slug":"self-diagnosed-covid-19-in-people-with-multiple-sclerosis-a-community-based-cohort-of-the-uk-ms-register","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/08\/28\/self-diagnosed-covid-19-in-people-with-multiple-sclerosis-a-community-based-cohort-of-the-uk-ms-register\/","title":{"rendered":"Self-Diagnosed COVID-19 in People with Multiple Sclerosis: A Community-Based Cohort of the UK MS Register"},"content":{"rendered":"<ul>\n<li>A prospective observational cohort study found that people with multiple sclerosis (MS) and those taking immunomodulatory disease-modifying therapies were not at elevated risk of COVID-19. Among people with MS, 237 of 3,910 (6%) participants reported self-diagnosed COVID-19, which was a similar risk to among their siblings without MS (OR: 1.2, 95%CI: 0.9-1.6). Participants taking disease-modifying therapies were less likely to have self-diagnosed COVID-19 (OR=0.64, 95% CI: 0.43-0.96).<\/li>\n<\/ul>\n<p><em>Evangelou et al. (Aug 27, 2020). Self-Diagnosed COVID-19 in People with Multiple Sclerosis: A Community-Based Cohort of the UK MS Register. Journal of Neurology, Neurosurgery &amp; Psychiatry. <a href=\"https:\/\/doi.org\/10.1136\/jnnp-2020-324449\">https:\/\/doi.org\/10.1136\/jnnp-2020-324449<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A prospective observational cohort study found that people with multiple sclerosis (MS) and those taking immunomodulatory disease-modifying therapies were not at elevated risk of COVID-19. Among people with MS, 237 of 3,910 (6%) participants reported self-diagnosed COVID-19, which was a similar risk to among their siblings without MS (OR: 1.2, 95%CI: 0.9-1.6). Participants taking disease-modifying&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/08\/28\/self-diagnosed-covid-19-in-people-with-multiple-sclerosis-a-community-based-cohort-of-the-uk-ms-register\/\">Read more<\/a><\/div>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[27],"topic":[19],"class_list":["post-585","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-testing","topic-testing-and-treatment"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/585","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=585"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/585\/revisions"}],"predecessor-version":[{"id":586,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/585\/revisions\/586"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=585"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=585"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=585"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=585"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}